APA (7th ed.) Citation

J-, R., F, B., R, C., M, M., SA, W., & LA, F. (2019). Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: A network meta-analysis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 30(7), 1465. https://doi.org/10.1007/s00198-019-04947-2

Chicago Style (17th ed.) Citation

J-, Reginster, Bianic F, Campbell R, Martin M, Williams SA, and Fitzpatrick LA. "Abaloparatide for Risk Reduction of Nonvertebral and Vertebral Fractures in Postmenopausal Women with Osteoporosis: A Network Meta-analysis." Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 30, no. 7 (2019): 1465. https://doi.org/10.1007/s00198-019-04947-2.

MLA (9th ed.) Citation

J-, Reginster, et al. "Abaloparatide for Risk Reduction of Nonvertebral and Vertebral Fractures in Postmenopausal Women with Osteoporosis: A Network Meta-analysis." Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, vol. 30, no. 7, 2019, p. 1465, https://doi.org/10.1007/s00198-019-04947-2.